NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · LARGE CAP
Merit Medical Systems Inc. MMSI
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$1.5B
▲ 11.8% vs FY2024
EPS · FY25
$2.13
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
8.7%
Net margin · FY25
8.5%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.5B
Revenue, FY2025 · full 17-year series below
Revenue
Net income
8 cents of every revenue dollar became profit this year.
Per share
USD 2.13
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
8.7%
Return on equity, FY2025
ROE
Operating margin12.2%
Net margin8.5%
Return on assets5.0%
Each USD of equity produced 9 cents of profit this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+9.5% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+9.6%
+9.5%
+10.8%
+11.5%
Net income
+19.9%
+18.4%
+16.8%
EPS, diluted
+18.2%
+14.9%
+12.8%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.06B
Shares outstanding, FY2025
Change, 5 years+6.8%
Change, 10 years+34.2%
The share count grew 7% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 2.7B
total assets, end of FY2025
Total assetsUSD 2.7B
EquityUSD 1.6B
CashUSD 446.4M
Gross debtUSD 734.0M
Net debtUSD 287.6M
Current ratio4.34×
Net debt stands at 18% of equity.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
1.5
1.4
1.3
1.2
1.1
1.0
1.0
0.9
0.7
0.6
0.5
0.5
0.4
0.4
0.4
0.3
0.3
Operating income $B
0.2
0.2
0.1
0.1
0.1
−0.0
0.0
0.1
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EBITDA $B
0.3
0.3
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.0
0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Net income $B
0.1
0.1
0.1
0.1
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EPS, diluted $
2.13
2.03
1.62
1.29
0.84
−0.18
0.10
0.78
0.55
0.45
0.53
0.53
0.39
0.46
0.58
0.35
0.63
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
8.7
9.3
8.0
6.8
4.8
−1.0
0.6
5.2
4.7
4.2
5.3
5.5
4.2
5.2
·
·
·
Shares out B
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.05
0.05
0.04
0.04
0.04
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
66 of 66
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed